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spectrin-based skeleton uniformly underlies and
supports the plasma membrane of the resting platelet,
but remodels and centralizes in the activated platelet.
 
 
 
-Adducin, a phosphoprotein that forms a ternary complex
with F-actin and spectrin, is dephosphorylated and mostly
bound to spectrin in the membrane skeleton of the resting
platelet at sites where actin ﬁlaments attach to the ends of
spectrin molecules. Platelets activated through protease-
activated receptor 1, Fc
 
 
 
RIIA, or by treatment with PMA
phosphorylate adducin at Ser726. Phosphoadducin releases
from the membrane skeleton concomitant with its dissocia-
A
 
tion from spectrin and actin. Inhibition of PKC blunts adducin
phosphorylation and release from spectrin and actin, pre-
venting the centralization of spectrin that normally follows
 
cell activation. We conclude that adducin targets actin
ﬁlament ends to spectrin to complete the assembly of the
resting membrane skeleton. Dissociation of phosphoadducin
 
releases spectrin from actin, facilitating centralization of
spectrin, and leads to the exposure of barbed actin ﬁlament
ends that may then participate in converting the resting
platelet’s disc shape into its active form.
 
Introduction
 
Platelets circulate in blood as discs where they must with-
stand high shear stresses. To tolerate such perturbations,
the platelet has developed a highly organized cytoskeleton,
which includes a peripheral microtubule coil and cross-
linked actin filaments that fill the cytoplasmic space and
connect to a membrane skeleton composed of spectrin and
its associated proteins. In RBCs, the spectrin lattice forms
a planar structure that laminates and supports the cytoplas-
mic face of the plasma membrane, providing an elastic matrix
that returns shear-deformed red cells to a biconcave shape.
The membrane skeleton of the platelet contributes to dis-
coid shape (Fox et al., 1988; Hartwig and DeSisto, 1991).
However, the platelet responds to vasculature damage by
rapidly changing shape, first becoming round, and then
extending filopodia and lamellae. These morphological
changes require alterations in the membrane skeleton as
well as actin remodeling.
The membrane skeleton of the platelet is a planar network
assembled primarily from spectrin molecules. In the erythro-
cyte, spectrin is joined into a network through attachments
to short actin filaments. These 14-mers of actin are stabilized
at their rapidly exchanging (barbed) ends by adducin (Kuhlman
et al., 1996; Li et al., 1998), at their slow-exchanging
(pointed) ends by tropomodulin (Ursitti and Fowler, 1994;
Weber et al., 1994), and along their lengths by tropomyosin
(Ursitti and Fowler, 1994). One significant difference between
the platelet and erythrocyte is that the platelet contains con-
siderably more actin, of which 
 
 
 
40% is assembled into long
 
filaments measuring 
 
 
 
1 
 
 
 
m in length on average, provid-
ing platelets with 2,000–10,000 actin filaments (Hartwig,
1992). Whether or not platelets contain a specialized pool of
short, membrane-associated actin filaments that cross-link
spectrin molecules has been debated (Fox, 1993; Fox et al.,
1988). If the ends of long actin filaments join the spectrin
network, how these ends target the membrane skeleton requires
an explanation.
Adducins comprise a protein family encoded by three
genes (
 
 
 
, 
 
 
 
, and 
 
 
 
). The 
 
 
 
 and 
 
 
 
 isoforms (M
 
r
 
 of 103,000
and 84–86,000, respectively) are ubiquitously expressed in
human cells; the 
 
 
 
 isoform (M
 
r
 
 of 97,000) is abundant in
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erythrocytes and the brain. Subunits assemble into het-
erodimers, or larger oligomers, through interactions in the
globular amino-terminal head domains. In addition, assem-
bly probably occurs through interactions near or within a
myristoylated alanine-rich C-kinase substrate (MARCKS)*
domain by the carboxyl-terminus (Hughes and Bennett,
1995), which contains PKC phosphorylation sites (Bennett
et al., 1988) as well as binding sites for calcium/calmodulin
(Gardner and Bennett, 1986) and possibly phospholipids.
Adducin caps the barbed ends of actin filaments (Kuhlman
et al., 1996; Li et al., 1998) and promotes their association
with spectrin (Gardner and Bennett, 1987). However, phos-
phorylation of purified adducin by PKC diminishes its in-
teraction with actin and spectrin (Matsuoka et al., 1998),
whereas addition of exogenous calcium/calmodulin releases
adducin from actin (Kuhlman et al., 1996). Together, these
findings indicate that adducin may be involved in exposing
 
*Abbreviations used in this paper: Arp, actin-related protein; GF, GF
109203X; MARCKS, myristoylated alanine-rich C-kinase substrate;
OG, 
 
n
 
-octyl 
 
 
 
-
 
D
 
-glucopyranoside; PAR, protease-activated receptor;
TRAP, thrombin receptor–activating peptide.
Figure 1.   -Adducin localizes to 
periodic sites that are likely to be the 
ends of spectrin tetramers. (A) Resting 
platelet cytoskeletons were labeled with 
10 nm gold coated with goat anti–rabbit 
IgG. Gold is found in small clusters 
separated by  200 nm at the ends of 
triangular pores (B) that are evenly 
distributed across the membrane 
skeleton. The distance between adjacent 
clusters is 201   46 nm (n   55). The 
inset shows the frequency length 
distribution of the intercluster distance. 
(C) A more open area of the membrane 
skeleton showing that anti-adducin 
labeling is found at the intersection of 
fibers. (D) Resting platelet cytoskeletons 
were sedimented onto glass coverslips 
without fixation to fracture the 
cytoskeleton and thus separate the 
spectrin-rich membrane skeleton from 
the core of F-actin. This image shows the 
membrane skeleton consisting primarily 
of spectrin filaments. Spectrin filaments 
are distinguished from actin, which has 
a rope-like appearance here, by virtue of 
labeling with myosin S1. Adducin is 
found almost exclusively in the spectrin-
rich region. Arrows indicate the polarity 
of F-actin by pointing in the direction of 
the slow-growing or “pointed” end. 
Bars, 200 nm.T
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actin filament barbed ends in motile cells after activation of
certain signal transduction cascades. Consequently, adducin
may be implicated in the development of actin assembly
sites (Falet et al., 2002; Ichetovkin et al., 2002). Further-
more, signaling cascades that elevate intracellular calcium or
activate PKC would destabilize the triadic interaction of ad-
ducin, actin filament barbed end, and spectrin, thereby po-
tentially triggering perturbations in the spectrin network.
Recent evidence suggests that adducin may also play a role
in the dynamics of the platelet membrane skeleton; adducin
is expressed in platelets (Gilligan et al., 1999) and becomes
phosphorylated and proteolyzed after platelet activation
(Gilligan et al., 2002). The works presented here link addu-
cin’s interactions with spectrin and actin filaments to modu-
lation of the membrane skeleton organization in the resting
and active platelet.
 
Results
 
Adducin is a component of the resting platelet 
membrane skeleton where it links actin filament 
barbed ends to spectrin
 
Fig. 1 shows that immunogold particles recognizing anti-
 
 
 
–adducin IgG associate with the lattice-like membrane skele-
ton of the discoid platelet. It has been previously shown that
spectrin is the main component of this fibrous lattice (Boyles
et al., 1985; Hartwig and DeSisto, 1991). Detailed examina-
tion of anti-adducin immunogold-labeled specimens reveals
that small clusters of 3–5 gold particles decorate the mem-
brane skeleton uniformly at intersections composed of two
or more strands: the thin fibers are likely to be spectrin, and
the thicker (10 nm) filaments are actin. The spacing of indi-
vidual gold clusters in Fig. 1 is consistent with 
 
 
 
-adducin’s
association within the membrane skeleton near the ends of
spectrin molecules at the points where actin filament ends
insert. If platelet spectrin organizes as tetramers, as in the
RBC membrane skeleton (Shotton et al., 1979; Liu et al.,
1984), then the predicted distance between adducin mole-
cules (gold clusters) bound to the 
 
 
 
-spectrin amino-termini
would be 
 
 
 
200 nm. As shown in Fig. 1 B, gold particle
clusters are separated from neighboring clusters by an aver-
age distance of 201 
 
 
 
 46 nm (mean 
 
 
 
 SD, 
 
n
 
 
 
 
 
 55). Fila-
ment intersections and localization of adducin at these inter-
sections are readily visible in Fig. 1 C (arrows), which
depicts a distended region of the membrane skeleton.
We also localized 
 
 
 
-adducin after labeling the membrane
skeleton with myosin S1. After treatment with myosin S1,
anti-
 
 
 
–adducin immunogold localizes near the end of un-
decorated strands (Fig. 1 D), but not to S1-decorated actin
filaments. Actin filament barbed ends can be seen to associ-
ate primarily with the membrane skeleton (Fig. 1 D: arrows
define polarity of filaments, with the direction of the arrows
pointing toward the minus or pointed end).
 
Spectrin is centralized while adducin is released in 
active platelet cytoskeletons
 
In metal replicas, the center of the spread platelet cytoskele-
ton is composed of a dense region of compact fibrous mate-
rial (Hartwig, 1992). This fibrous material is densely labeled
with 10 nm anti-spectrin immunogold (Fig. 2 A), whereas
only sparse gold labeling is found in the rest of the cytoskel-
eton (Fig. 2 B). This suggests that the fibrous material is the
remnant of the membrane skeleton aggregating in the center
during platelet spreading. Furthermore, although spectrin is
redistributed into the center of active platelet cytoskele-
tons, immunoelectron microscopy analysis shows that little
 
 
 
-adducin remains associated with the active cytoskeleton (Fig.
2, C and D). Anti-adducin immunogold labeling is sparse in
both the core of the cytoskeleton (Fig. 2 C) and in the cor-
tex, where actin filaments are dense (Fig. 2 D). Quantitation
of anti-adducin immunogold particles in electron micro-
graphs of cytoskeletons revealed that there was 72% less gold
label in the active versus resting cytoskeleton (11.4 
 
 
 
 6.2
and 39.8 
 
 
 
 17 gold particles/
 
 
 
m
 
2
 
, respectively).
A comparison of immunofluorescent staining of fixed
platelets and detergent-extracted cytoskeletons of platelets ac-
tivated when sedimented onto glass further confirms that lit-
tle 
 
 
 
-adducin remains in detergent-permeabilized platelets
(Fig. 3; cytoskeleton denotes platelets permeabilized with de-
tergent before fixation). F-actin staining with Alexa
 
®
 
 488–
phalloidin (green) delineates the cell boundaries in both in-
tact cells (fixed before detergent) and cytoskeletons. These
images also reveal the distribution of total adducin (mostly
phosphoadducin in the active platelet). As detailed in the sec-
tion entitled Adducin is phosphorylated by PKC in active
platelets, the bulk of adducin becomes phosphorylated and
soluble after platelet activation. Therefore, adducin remain-
ing in the cytoskeleton is dephosphorylated, and some resid-
ual adducin staining in the dense center of the cytoskeleton
occurs. In intact platelets, adducin staining (Texas red) is ro-
bust and found uniformly throughout the spread cell, as well
as in the dense central area. To further understand the addu-
cin–spectrin interaction, we compared the distribution of
spectrin and adducin to F-actin in spread platelets (Fig. 3). In
similar fashion to adducin, spectrin centralizes after platelet
activation and spreading, although spectrin is concentrated in
the center of the cells relative to adducin, which appears in
both the cell center and the spread lamellae. After permeabili-
zation to remove soluble phosphoadducin, both spectrin and
adducin stain only the cytoskeletal centers of platelets. The
centralization of spectrin and adducin requires actin assem-
bly because centralization is greatly diminished in platelets
treated with 2 
 
 
 
M cytochalasin B. This effect is most appar-
ent in the centralization of spectrin (Fig. 3). Examination of
adducin and spectrin localization during platelet spreading
further delineates the membrane skeletal remodeling process
(Fig. 4). Both adducin and spectrin localize throughout the
resting platelet. By 1.5 min after the onset of surface activa-
tion, the earliest time we could reproducibly obtain adherent
and active platelets, adducin and spectrin remain centrally lo-
cated in an area corresponding to the previous boundaries of
the resting platelet that is separate from the zone of new actin
polymerization at the edge of the cell. As platelets continue to
spread with longer times (5 min) on glass, F-actin staining in
the center of the platelet becomes reduced as spectrin con-
denses into the cell center. A significant portion of the addu-
cin remains centrally located at 5 min after activation, al-
though some staining does extend into lamellae, which we
believe represents soluble phosphoadducin.T
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Figure 2. Localization of spectrin in the cytoskeleton of a spread platelet by immunoelectron microscopy. (A and B) high magnification 
images of those indicated in the inset. Dense binding of 10 nm immunogold anti-spectrin is found in the center of the cytoskeleton (A), 
whereas only sparse gold labeling is found in the rest of the cytoskeleton (B). (C and D) Immunogold labeling of platelet cytoskeletons shows 
little adducin remaining in the center (C) or in the cortex (D) after activation. Bars, 200 nm.T
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Centralization and dissociation of adducin and spectrin 
are inhibited by GF
 
To determine if spectrin centralization during platelet
spreading involves PKC-mediated dissociation of adducin
from spectrin, platelets were allowed to spread in the pres-
ence of 5 
 
 
 
M GF 109203X (GF), a selective inhibitor of
PKC (Toullec et al., 1991). GF prevents the bulk release of
adducin into the detergent-soluble fraction after stimulation
with agonists (see section entitled Adducin is phosphory-
lated by PKC in active platelets). As shown in Fig. 3, inhibi-
tion of PKC slows the accumulation of adducin, spectrin,
and F-actin in the platelet center; instead, actin and spectrin
coalesce into a broad pericentral zone when platelets spread
in the presence of GF. Adducin centralization is also af-
fected, but to a lesser extent. GF does not affect the initial
stages of adducin and spectrin remodeling as platelets spread
on glass (1.5 min), as both proteins remain condensed in the
cell center (Fig. 4). However, after longer times of spreading
(5 min), adducin does not redistribute to the cell cortex (Fig.
4, compare untreated with 
 
 
 
GF), and spectrin concentrates
in a new ring structure along with F-actin in the middle of
platelets treated with GF. 5 min after activation, PKC activ-
ity normally dissociates actin from spectrin. Hence, GF
blocks the bulk export of spectrin from the platelet center.
In an attempt to quantify these processes, we compared the
platelet area cooccupied by actin and adducin or spectrin.
Quantitative analysis of the fluorescent staining of platelets
demonstrates that spectrin (Fig. 4, top graph) and adducin
 
(Fig. 4, bottom graph) couple tightly to F-actin in platelets
treated with GF, whereas the area of overlap declines over
time in untreated platelets. However, these measurements
do not take staining intensities into account, and therefore
do not provide spatial protein concentrations.
 
Biochemical evidence indicates that the majority 
of adducin is associated with the cytoskeleton 
in resting platelets
 
The concentration of 
 
 
 
-adducin in platelets was determined
by quantitative immunoblotting. A pAb against 
 
 
 
-adducin
detected 2.7 
 
 
 
 0.3 ng of adducin per 
 
 
 
g of total platelet pro-
tein, equivalent to a platelet concentration of 
 
 
 
3 
 
 
 
M (un-
published data). When resting platelets permeabilized with
Triton X-100 are centrifuged at high 
 
g
 
 forces (
 
 
 
100,000 
 
g
 
),
proteins associated with F-actin pellet. As shown in Fig. 5
(D–F; time 
 
  
 
0), 
 
 
 
70–75% (2.15 
 
 
 
 0.1 
 
 
 
M, 
 
n
 
 
 
  
 
6) of
 
 
 
-adducin pellets in detergent-lysed resting platelets.
 
Adducin is phosphorylated by PKC in active platelets
 
To investigate adducin’s PKC-dependent phosphorylation
state in resting and activated platelets, we used mAb that
recognizes the PKC phosphorylation site in 
 
 
 
-adducin
(p-Ser726) and detects phosphoadducin only in activated
platelets. Fig. 5 shows the kinetics of 
 
 
 
-adducin phosphory-
lation (
 
n
 
 
 
  
 
3) in platelets stimulated through protease-activated
receptor 1 (PAR-1; Fig. 5 A), Fc
 
 
 
RIIA (Fig. 5 B), and PMA
Figure 2 continued.T
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(Fig. 5 C). Resting platelets (time 
 
  
 
0) have little phospho-
adducin in either their cytoskeletons (Fig. 5, A–C, p) or sol-
uble protein fractions (Fig. 5, A–C, s). Phosphoadducin is
detectable by 15 s and maximal 30–60 s after treating plate-
lets with 25 
 
 
 
M thrombin receptor–activating peptide
(TRAP) to ligate PAR-1 (Fig. 5 A). Platelets activated
through Fc
 
 
 
RIIA have maximal levels of phosphoadducin
2–3 min after activation (Fig. 5 B). When platelets are acti-
vated with 100 nM PMA, phosphoadducin is evident at 1–5
min, but the bulk of PKC-dependent phosphorylation re-
quires 10–15 min of exposure to PMA (Fig. 5 C). Phosphor-
ylation of 
 
 
 
-adducin induced by agonists is inhibited by 5
 
 
 
M GF (Fig. 5, A and C).
 
Dissociation of 
 
 
 
-adducin from the activated 
platelet cytoskeleton
 
Once phosphorylated at Ser726, adducin no longer sediments
with the F-actin cytoskeleton. Furthermore, after platelet acti-
vation through PAR-1 (Fig. 5 E), Fc
 
 
 
RIIA (Fig. 5 E), or by
PMA (Fig. 5 F), phosphoadducin is recovered only in the sol-
uble fraction after centrifugation at 100,000 
 
g
 
. However, the
kinetics of 
 
 
 
-adducin release are different for the three ago-
Figure 3. Immunofluorescent localization of adducin, spectrin, and F-actin in platelets spread on glass. The protein stained and fluorophore of 
the secondary antibody are indicated in each panel. Samples pretreated with 5  M GF or 2  M cytochalasin B are indicated. “Cytoskeleton” 
denotes platelets first extracted with Triton X-100 before fixation. All other panels show intact and fixed platelets. Bar, 5  m.T
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nists. Stimulation through PAR-1 leads to the most rapid re-
lease of adducin, which begins within seconds and is maximal
by 2 min after activation. In contrast, treatment with PMA
induces the slowest response, requiring 15 min for the maxi-
mal release of adducin. 
 
 
 
-Adducin release in Fc
 
 
 
RIIA-ligated
platelets is intermediate, with maximal release requiring 3–4
min. In all cases, 10–25% of the total 
 
 
 
-adducin remains un-
phosphorylated and associated with the detergent-insoluble
F-actin cytoskeleton of the activated platelet.
 
Adducin releases from spectrin 
during platelet activation
 
Biochemical experiments further support the finding that ad-
ducin physically associates with spectrin in the membrane skel-
eton. To specifically examine the effects of phosphorylation on
the interaction of adducin with spectrin, total adducin was im-
munoprecipitated from lysates of resting and PAR-1–ligated
platelets and immunoblotted with anti-spectrin antibodies.
Quantitative immunoblots revealed that 75 
 
 
 
 12% (
 
n
 
 
 
  
 
4)
of the total spectrin in platelets associates with adducin in
the resting cell (Fig. 6 A, squares, time 
 
  0). After ligation of
PAR-1, less spectrin was found in association with adducin in
immunoprecipitates prepared from platelet lysates (Fig. 6 A,
squares). Spectrin dissociation from adducin was rapid and
reached a maximal value by 1 min, at which point 65–70% of
the spectrin had dissociated. We also examined the effect of
GF on the spectrin–adducin interaction and found that GF
prevents the release of spectrin from adducin (Fig. 6 A, dia-
monds). The membrane skeleton and actin filament core of
the platelet can also be separated into distinct biochemical
populations after detergent permeabilization using differential
centrifugation (Fox et al., 1988). The core cytoskeleton, com-
posed of long cross-linked actin filaments, sediments at 15,000
g. In contrast, the membrane skeleton containing the spectrin
lattice and its associated proteins, including some actin fila-
ments, sediments only at higher forces of  100,000 g. Addu-
cin’s sedimentation profile follows that of the membrane skele-
ton;   75% of adducin resides in the pellet sedimented at
 100,000 g (Fig. 6 B, hp) and only a small amount of adducin
is associated with the low speed pellet (Fig. 6 B, lp). We used
differential centrifugation to determine if adducin releases
from the platelet membrane skeleton after addition of PMA.
As shown in Fig. 6 B, there was a bulk transition of  -adducin
out of the high speed pellet, which contains spectrin and the
membrane skeleton, and into the high speed supernatant. The
small amount of adducin in the 15,000 g pellet, which con-
tains the core cytoskeleton, did not change with activation.
What signaling components participate in adducin 
release from the cytoskeleton?
To directly determine if PKC-mediated phosphorylation
could release adducin from platelet actin, the purified cata-
Figure 4. Immunofluorescent localization of adducin, spectrin, and F-actin as platelets spread for 1.5 or 5 min. The protein stained and 
fluorophore of the secondary antibody is indicated in each panel. Samples treated with GF are indicated. Panels showing resting platelets are 
located in the top left. Bar, 5  m. GF treatment reduces the separation of actin from spectrin and adducin. The two graphs in the bottom left 
quantify the amount of colocalization of F-actin staining with spectrin (top graph) or adducin (bottom graph) staining during normal platelet 
spreading (squares with black lines) or spreading in the presence of 5  M GF109203X (diamonds with red lines) with respect to the incubation 
time (mean   SD, n   10).T
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lytic subunit of PKC was added to detergent-permeabilized,
washed platelets. As shown in Fig. 7 A, treatment with puri-
fied PKC releases phosphoadducin from the membrane skel-
eton into a 215,000 g soluble fraction. Because many actin
filament barbed-end capping proteins are released from ac-
tin by polyphosphoinositides and because the MARCKS do-
main of other proteins also interacts with phospholipids, we
examined whether  -adducin could also be released by poly-
phosphoinositide micelles in n-octyl   -D-glucopyranoside
(OG)-permeabilized and washed platelets. We found that
75  M PI4,5P2 or PI3,4P2 (or PI3,4,5P3, unpublished data) re-
leases  -adducin from these permeabilized platelets, but the
same concentration of phosphatidylserine has no effect on
adducin release (Fig. 7 B).
Because the MARCKS domain of adducin has calcium/
calmodulin binding sites, we additionally sought to deter-
mine whether cytosolic calcium transients play a role in ad-
Figure 5.  -Adducin is bound to the actin cytoskeletons of resting platelets and is phosphorylated and released from the cytoskeletons of 
active platelets. (A–C) Phosphorylation of adducin at Ser726 follows platelet activation by PAR-1 (A), Fc RIIA (B), and PMA (C). The kinetics 
of adducin phosphorylation are plotted (mean   SD, n   3). Insets (A and C) show representative Ser726 phosphoimmunoblots   GF for 
PAR-1 and PMA activation. (D–F) The amount of adducin associated with F-actin in 215,000 g pellets of permeabilized platelets (squares) 
activated by PAR-1 (D), Fc RIIA (E), or PMA (F) is compared with platelets treated before permeabilization with either GF (diamonds, D–F) or 
EGTA-AM (circles, D and F).
Figure 6.  -Adducin associates with spectrin in resting platelets, 
but dissociates during platelet activation. (A) Percentage of total 
spectrin that immunoprecipitates with adducin in resting platelets or 
platelets activated with 25  M TRAP (squares). Less spectrin associates 
with  -adducin after platelet activation. Dissociation of spectrin 
from adducin is prevented when platelets are incubated with the 
PKC inhibitor GF 109203X (diamonds). (B) Distribution of adducin 
in the cytoskeleton (lp, 15,000 g low speed pellet), membrane 
skeleton (hp, 215,000 g high speed pellet), and soluble (s, high speed 
supernatant) phase of PMA-stimulated platelets permeabilized with 
Triton X-100 and detected by immunoblot.T
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ducin release. Accordingly, platelets were treated with 40
 M EGTA-AM to chelate calcium. Chelation inhibits the
release of adducin from the platelet membrane skeleton af-
ter PAR-1 stimulation (Fig. 5 D, circles). However, in
PMA-treated platelets, which do not normally undergo in-
tracellular calcium transients (Falet and Rendu, 1994),
EGTA-AM has little effect on the release of adducin from
actin (Fig. 5 F, circles).
A recent report indicated that adducin is cleaved by
calpain, a calcium-dependent cytoplasmic protease, in plate-
lets activated by thrombin (Gilligan et al., 2002). However,
we find that treatment of platelets with calpeptin, an inhibi-
tor of calpain’s proteolytic activity, does not alter the kinet-
ics of adducin release (unpublished data). Our experiments
do not indicate that  -adducin is cleaved by calpain in plate-
lets activated by a PAR-1–specific activating peptide, cross-
linking of Fc RIIA, or by phorbol esters.
Furthermore, because it has been reported that adducin is
phosphorylated by rho kinase, an event that affects adducin–
actin interactions (Kimura et al., 1998; Fukata et al., 1999),
we examined the effect of the rho kinase inhibitor, Y-27632,
on the association of adducin with actin. Adducin release
was unaffected in platelets that were pretreated with 5  M
Y-27632 and activated by PAR-1, Fc RIIA, or PMA (un-
published data). Nonetheless, we confirmed that 5  M
Y-27632 blocked LPA-induced stress fiber formation in se-
rum-starved fibroblasts (unpublished data), a process medi-
ated by rho kinase (Amano et al., 1997).
Adducin phosphorylation by PKC and its release from 
the cytoskeleton coincide with actin assembly and 
barbed-end exposure
Regardless of how platelets are activated, phosphorylation
of  -adducin at Ser726 coincides with actin filament as-
sembly and actin filament barbed-end exposure. Release of
adducin from the platelet membrane skeleton might con-
tribute to barbed-end exposure and the onset of actin as-
sembly in active platelets. Accordingly, we examined the
role of PKC-mediated adducin phosphorylation in the ac-
tin assembly reaction of platelets stimulated either through
PAR-1, Fc RIIA, or by the addition of PMA. Platelets ac-
tivated through PAR-1 show a small but reproducible re-
duction in actin assembly and barbed-end exposure when
treated with GF, as compared with untreated controls (Fig.
8, A and B). This small effect on barbed ends and actin as-
sembly is consistent with the GF-insensitive, barbed-end
nucleation activity of gelsolin and actin-related protein 2/3
(Arp2/3; see section entitled Adducin releases from spec-
trin during platelet activation). Barbed-end exposure and
actin assembly in platelets activated through the Fc RIIA
receptor are more sensitive to PKC inhibition. In Fc -
RIIA-activated platelets, GF inhibits actin assembly by
 70% (Fig. 8 C) and suppresses barbed-end exposure by
 40–80% at early time points (Fig. 8 D). As expected, in-
hibition of PKC in platelets exposed to PMA blocks
 95% of both actin assembly (Fig. 8 E) and barbed-end
exposure (Fig. 8 F).
Because other proteins can regulate actin filament barbed-
end exposure, we investigated the effect of GF on the trans-
location of gelsolin and capZ, two actin filament barbed-end
capping proteins, as well as on the actin-nucleating Arp2/3
complex. As shown in Fig. 9, GF affects neither the revers-
ible entry of gelsolin nor the incorporation of the Arp2/3
complex and capZ into the cytoskeletons of platelets acti-
vated through PAR-1. In addition, the association of the
Arp2/3 complex and gelsolin with actin does not change in
PMA-treated platelets. Nonetheless, capZ does associate
with the actin cytoskeleton of PMA-treated platelets, as ex-
pected from the increase in the number of barbed ends. The
association of capZ with actin is blocked when platelets are
treated with GF (Fig. 9).
Discussion
Here, we confirm that platelets express  -adducin (Gilligan
et al., 1999) and show it is a structural protein of the resting
cytoskeleton, bound to both spectrin and F-actin. After
platelet activation, phosphorylation of adducin at Ser726 re-
leases it from spectrin and F-actin. Release of adducin from
spectrin facilitates the centralization of the membrane skele-
ton during platelet spreading. Release of adducin from F-actin
exposes actin barbed ends that contribute to the actin assem-
bly reactions in lamellae and filopodia.
Adducin is believed to self-associate into heterodimers and
heterotetramers (Hughes and Bennett, 1995; Li et al.,
1998) composed of  ,   , or   isoforms. Because most
mammalian cells express little of the erythroid   isoform,
adducin molecules in platelets are   and   assemblies
(based on an  -adducin concentration of 3  M and a vol
of 7 fl, each platelet expresses  12,600   -adducin sub-
units). Depending on whether adducin is a heterodimer
(1 :1 ) or heterotetramer, each platelet would have either
12,600 or  6,300 adducin molecules, respectively. The
theoretical maximal number of adducin binding sites at
spectrin ends is 4,000 because each platelet has  2,000
spectrin tetramers (Hartwig and DeSisto, 1991). As  70%
Figure 7. Treatment of permeabilized, washed platelets with the 
catalytic subunit of PKC or PI3,4P2 micelles releases  -adducin from 
the cytoskeleton. (A) Platelets were extracted with 0.4% OG and 
washed twice in PHEM without OG. They were treated with the 
catalytic subunit of PKC (Sigma-Aldrich) at the indicated times, and 
then centrifuged to generate pellet (p) and supernatant (s) fractions. 
Immunoblots of total cytoskeletal  -adducin (top immunoblot) or 
Ser726 phospho– -adducin (bottom immunoblot) are shown. 
(B) Immunoblots of total  -adducin in cytoskeletal pellets (p) 
and soluble fractions (s) of permeabilized platelets treated with 
phosphatidylserine (PS), PI3,4P2, or PI4,5P2.T
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of adducin is bound to spectrin in the resting platelet, the
number of bound adducin complexes is  4,400, which is
close to this theoretical maximum. On the other hand, the
number of actin filaments in a resting platelet has been esti-
mated at 2,000–10,000. Therefore, each resting platelet has
a sufficient amount of adducin to cap many of these ac-
tin filaments and to target them to spectrin in the mem-
brane skeleton. In addition, resting platelets have a signifi-
cant portion of their actin filament barbed ends capped by
capZ. We have previously reported that  7,000 capZ mol-
ecules associate with the resting cytoskeleton (Barkalow et
al., 1996). If the higher estimate for actin filaments is accu-
rate, then the adducin and capZ bound to actin filament
ends would account for the  98% capping of the barbed
ends (Hartwig, 1992). However, if the lower estimate for ac-
tin filaments is correct, a significant portion of the ad-
ducin and capZ would be associated with other Triton
X-100–insoluble elements, such as lipid rafts that are rich in
polyphosphoinositides.
The association of adducin with both actin filament
barbed ends and spectrin is regulated by PKC-dependent
phosphorylation of adducin (Matsuoka et al., 1998). Addu-
cin associates with the platelet membrane skeleton, but dis-
sociates when phosphorylated by PKC at Ser726, consistent
with the finding that phosphorylation by PKC within ad-
ducin’s MARCKS domain separates it from both actin fila-
ments and spectrin. In addition, Gilligan et al. (2002)
reported that adducin releases from detergent-insoluble cy-
toskeletons of thrombin-activated platelets, and that its re-
lease coincides with phosphorylation by PKC. Adducin also
has a calcium/calmodulin binding site (Gardner and Ben-
nett, 1986), and treatment with exogenous calcium/cal-
modulin releases adducin from RBC ghosts (Kuhlman
et al., 1996). For most agonists, maximal actin filament
barbed-end exposure or production after platelet activation
requires a transient increase in intracellular calcium. Thus,
it seems likely that calcium/calmodulin binding may help
release adducin from the barbed ends of actin filaments in
platelets. Platelets treated with PMA do not undergo fluctu-
ations in intracellular calcium (Falet and Rendu, 1994), yet
do manifest a slow but significant dissociation of adducin
from actin that is unaffected by treatment with EGTA-AM.
Furthermore, actin nucleation is independent of gelsolin
(Fig. 9) because gelsolin does not become transiently acti-
vated to move into the PMA-activated cytoskeleton. To-
gether, these findings suggest that release of adducin from
the membrane skeleton does not require binding of cal-
cium/calmodulin.
Polyphosphoinositides may also influence the adducin–
actin–spectrin interaction by interacting with adducin’s
Figure 8. Actin assembly and barbed-end exposure are diminished by inhibiting PKC. (A and B) Cytoskeletal changes are temporally linked 
to the phosphorylation and release of adducin from the cytoskeleton. (A) F-actin content and (B) barbed-end exposure in resting platelets and 
platelets stimulated through PAR-1 in the absence (squares) or the presence (diamonds) of GF. (C and D) Comparison of F-actin content (C) 
and free barbed ends (D) in platelets activated through Fc RIIA in the absence (squares) or presence (diamonds) of GF. Both are reduced 
by 50–70% in platelets stimulated through Fc RIIA when PKC is inhibited. (E and F) Platelets stimulated by 100 nM PMA exhibit marked 
inhibition of F-actin assembly (E) and barbed-end exposure (F) when pretreated with GF (diamonds), compared with controls (squares).T
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MARCKS domain. Polyphosphoinositides bind to a motif
within the MARCKS protein (aa 151–175, referred to as the
MARCKS domain in other proteins containing this motif)
and are sequestered from PLC when bound (Glaser et al.,
1996). Phosphorylation of MARCKS by PKC dissociates
the lipid from MARCKS, releasing this constraint. Poly-
phosphoinositides also bind to actin filament barbed-end
binding proteins such as gelsolin (Janmey and Stossel, 1987)
and capZ (Schafer et al., 1996), and prevent/reverse their
binding. In light of these findings, we tested the ability of
polyphosphoinositides to modulate adducin binding in the
platelet cytoskeleton, and found that PI3,4P2, PI4,5P2 (Fig. 7),
and PI3,4,5P3 (unpublished data) each dissociated a portion
of the adducin bound to the cytoskeleton.
Platelet activation, which can be triggered by various ago-
nists, initiates platelet shape changes that are driven by
forces generated from polymerization at the barbed ends of
actin filaments. Different receptor-mediated signaling cas-
cades may invoke actin regulation with variable efficiencies
using a host of barbed-end capping proteins. In PAR-1–
stimulated platelets, the majority of free actin filament
barbed ends originate from gelsolin-driven severing and un-
capping amplified by Arp2/3 (Witke et al., 1995; Falet et
al., 2002); however, adducin does contribute some ( 10%)
of the total barbed ends generated. In platelets activated
through Fc RIIA and PMA, adducin contributes 60–100%
of the new actin filament barbed ends. This greater depen-
dence on adducin reflects the inactivity of gelsolin and
Arp2/3 under these signaling conditions. CapZ’s associa-
tion with the actin cytoskeleton in PMA-activated platelets
is not surprising because its primary function in active
platelets is to cap free barbed ends (Barkalow et al., 1996).
Although adducin-mediated nucleation activity may con-
tribute only a small portion of barbed ends, the removal of
adducin from the membrane skeleton may be important
for efficient lamellar extension. Membrane destabilization
would occur as actin filament ends are released, thereby dis-
rupting the integrity of the spectrin lattice as adducin
strengthens the actin–spectrin interaction. Destabilizing the
membrane skeleton would in turn facilitate membrane ex-
tension during platelet spreading. Consistent with this hy-
pothesis is the observation that adducin releases from spec-
trin during platelet activation in a manner dependent on its
phosphorylation at Ser726 by PKC. Furthermore, the local-
ization of spectrin at the platelet center is severely hindered
when PKC activity is blocked in active platelets. Therefore,
we propose that the binding of  -adducin to spectrin in
resting platelets is important in maintaining the membrane
skeleton, and that remodeling of the membrane skeleton
during activation is achieved in part by  -adducin release
from spectrin.
Our structural and biochemical studies provide informa-
tion to refine the model of the membrane skeleton in resting
platelets and to begin to elucidate the dynamic changes after
platelet activation. As illustrated in Fig. 10, the membrane
skeleton of the resting platelet is a network of spectrin tet-
ramers that interconnect at actin filament ends. Adducin
molecules strengthen the spectrin–actin connections and
target actin filament barbed ends to spectrin. Because these
actin filaments are part of and are cross-linked to the actin
cytoskeleton, adducin acts as a bridge between the mem-
brane skeleton and the actin cytoskeleton. Platelet activation
alters both the actin cytoskeleton and the membrane skele-
ton. Within seconds after platelet activation (Fig. 10, early
event), Ca
2 -gelsolin severs preexisting actin filaments into
small fragments. The subsequent release of gelsolin from the
barbed ends of these filament fragments generates templates
onto which the Arp2/3 complex binds, and new actin fila-
ments are polymerized (Fig. 10, early events, new actin as-
sembly zone; Falet et al., 2002). Actin filaments grow off of
Arp2/3 as well as the free barbed ends and fill lamellae. In a
slower process (30 s–1 min), adducin releases from actin and
spectrin (Fig. 10, early events), freeing spectrin and allowing
the membrane skeleton to become centralized during plate-
let spreading (Fig. 10, later events). However, GF-treated
platelets do not release adducin from spectrin and actin.
Platelet activation in the presence of GF leads to structural
abnormalities; stabilization of the spectrin network prohibits
its centralization, leading to accumulation of spectrin and
actin filaments in a zone equivalent to the boundaries of
the resting cell (Fig. 10, late events). Nonetheless, actin
filaments remain susceptible to severing by Ca
2 -gelsolin.
Figure 9. Inhibition of PKC by GF does 
not alter the activation of gelsolin, capZ, 
or Arp2/3 in PAR-1–ligated platelets. 
Results from platelets stimulated by 
PAR-1 ligation or addition of PMA 
are shown. PMA does not induce an 
association of gelsolin or Arp2/3 with 
the cytoskeleton, but capZ does associate 
with the cytoskeleton in a PKC-dependent 
fashion. All data are expressed as a 
percentage of maximal association with 
the cytoskeleton (mean   SD, n   3).T
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Therefore, gelsolin-dependent actin nucleation as well as
lamellar extension, which drive platelet spreading, persist in
GF-treated platelets.
The binding of adducin to platelet spectrin and its local-
ization in the platelet membrane skeleton places adducin at
an important site to link actin filament barbed ends to spec-
trin and provides an explanation for how these actin fila-
ment ends find spectrin (Hartwig and DeSisto, 1991). Be-
cause adducin, spectrin, and actin filaments exist in all
mammalian cells, our findings may be relevant for the mem-
brane–cytoskeletal interfaces of other cell types as well. For
example, in translocating cells, the formation of adducin, ac-
tin, and spectrin complexes may reversibly assemble at de-
fined sites to facilitate directional motility.
Materials and methods
Antibodies
Anti–human  -adducin serum was obtained by immunizing New Zealand
white rabbits with aa 347–737 of human  -adducin as a GST fusion pro-
tein. A phosphoserine 726–specific mAb was generated in mice by inject-
ing the phosphopeptide phe-arg-thr-pro-ser (phospho)-phe-leu-lys-lys. The
mice were processed for mAb production by isolating cells from the
spleen, and fusing them with mouse myeloma cells (SB 2) to produce hy-
bridoma cells. The cells were then screened for antibody production spe-
cific to the phosphopeptide.
Isolation of platelets
Human platelets were isolated from anti-coagulated blood. Platelet-rich
plasma was obtained by centrifuging the blood at 200 g for 15 min. Plate-
lets were separated from the plasma by gel filtration over a Sepharose-2B
column preequilibrated with platelet buffer (145 mM NaCl, 10 mM
Hepes, 10 mM glucose, 0.3% BSA, 0.5 mM NaH2PO4, and 5 mM KCl, pH
7.4). The platelets were allowed to stand at 37 C for 30 min before further
treatment.
Platelet activation
Resting platelets were activated by (1) PAR-1 ligation with 25  M TRAP;
(2) 3  g/ml anti-Fc RIIA, followed by 30  g/ml goat anti–mouse F(ab )2 at
37 C; or (3) 100 nM PMA (phorbol 12-myristate 13-acetate). In some ex-
periments, platelets were pretreated with either 40  M EGTA-AM for 30
min or with 5  M GF 109203X, an inhibitor of PKC (Toullec et al., 1991),
for 1 min. At the appropriate times, platelets were lysed with 1/10 vol of
10  lysis buffer (120 mM Pipes, 60 mM Hepes, 100 mM EGTA, 20 mM
MgCl2, 1% Triton X-100, 10  M phallacidin, and 0.5 mg/ml each of leu-
peptin, aprotinin, and benzamidine, pH 6.9). Samples were centrifuged for
30 min at 215,000 g in a centrifuge (model TL-100; Beckman Coulter).
Platelet samples treated with PKC or PI3,4P2 micelles were extracted in lysis
buffer with 0.5% OG instead of Triton X-100. Supernatants and pellets
were mixed in equal volumes of SDS-PAGE sample buffer. All samples
were incubated at 37 C overnight.
Immunoprecipitation of adducin
Platelets at rest or activated with TRAP were extracted with lysis buffer.
Anti-adducin polyclonal serum was added at a 1:200 dilution, along with
20   l of packed GammaBind™ G Sepharose (Amersham Biosciences).
Samples were mixed at 4 C overnight. The Sepharose was sedimented at
1,000 g for 5 min. The supernatants were recovered and saved for SDS-
PAGE and immunoblotting. The Sepharose pellet was washed 5  with
platelet buffer and prepared for SDS-PAGE and immunoblotting.
SDS-PAGE and immunoblotting
SDS-PAGE was performed using a modified 8 or 15% acrylamide Laem-
mli slab gel (Laemmli, 1970). Proteins were transferred for 75–90 min to
PVDF membranes (Millipore) using a Trans-Blot
® cell (Bio-Rad Laborato-
ries) at 1 A. PVDF membranes were blocked in PBS with 0.02% Tween 20
and 5% Carnation nonfat dry milk, pH 7.4. Blocked membranes were in-
cubated with primary antibody for 2 h at RT, washed three times with
PBS, and probed with a 1:4,000 dilution of goat anti–rabbit IgG HRP con-
jugate (Bio-Rad Laboratories) for 1 h. Washed membranes were again
washed and developed using chemiluminescence (SuperSignal
®; Pierce
Chemical Co.).
Electron microscopy
Resting platelets were extracted with 0.75% Triton X-100, 0.1% glutaral-
dehyde, PHEM (60 mM Pipes, 25 mM Hepes, 10 mM EGTA, and 2 mM
MgCl2, pH 6.9), and 1  M phallacidin (glutaraldehyde is omitted if fractur-
ing of the cytoskeleton is desired as in Fig. 1 D), and attached by centrifu-
gation to poly-L-lysine–coated coverslips (Hartwig and DeSisto, 1991). The
adhered cytoskeletons were washed, and free aldehydes were blocked
with 0.1% sodium borohydride in PHEM. For analysis of activated platelet
cytoskeletons (e.g., Fig. 2), platelets were first centrifuged onto coverslips,
then detergent permeabilized (Hartwig, 1992). Myosin S1 labeling of cyto-
skeletons was achieved by incubating samples with 2 mg/ml myosin S1 for
5 min. The cytoskeletons were washed in PBS/1% BSA to block nonspe-
cific protein binding, incubated for 1.5 h at 22 C with anti-spectrin pAb di-
Figure 10. Diagram summarizing the reorganization of F-actin, 
spectrin, and adducin during platelet spreading. (Left) Normal 
spreading. The resting platelet has a spectrin lattice that laminates 
the cytoplasmic face of its plasma membrane. Adducin molecules 
sit at the intersections of spectrin tetramers and bind F-actin barbed 
ends. Changes in the adducin–actin–spectrin interaction occur as 
platelets become active. Platelet activation (early events) results in 
gelsolin-mediated F-actin severing and adducin release from spectrin–
actin, which destabilizes the membrane skeleton. (Later events) Actin 
polymerization and centralization of spectrin–dephosphoadducin–
F-actin follow the fragmentation phase of platelet activation. 
(Right) PKC inhibition slows spectrin centralization. F-actin is severed 
by gelsolin, but adducin is not phosphorylated and cannot release 
from spectrin–actin. Actin nucleation sites remain associated with 
the membrane skeleton because F-actin fragments remain bound 
to spectrin. This enhances actin assembly in the region of the 
membrane skeleton, which does not condense and remains dispersed 
in the center of the activated platelet. Spectrin, actin, and adducin 
are defined in the diagram.T
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luted to  10  g/ml in PBS/BSA, washed six times with PBS/BSA, and incu-
bated for 1.5 h with anti–rabbit IgG 10-nm colloidal gold conjugates. The
labeled cytoskeletons were extensively washed, fixed with 1% glutaralde-
hyde in PBS for 10 min, washed into distilled water, rapidly frozen, freeze-
dried, and rotary shadowed with 1.2 nm tungsten-tantalum at 45  followed
by 3 nm of carbon at 90  without rotation. Replicas were photographed
with an electron microscope (model 1200-EX; JEOL USA, Inc.) at a 100-kV
accelerating voltage.
Immunofluorescence
Resting platelets were centrifuged at 200 g for 5 min onto poly-L-lysine–
coated glass coverslips in platelet buffer with or without 5  M GF
109203X or 2  M cytochalasin B. Adherent platelets were fixed with 2%
formaldehyde in platelet buffer for 10 min, followed by 0.5% Triton X-100
in platelet buffer for 10 min. The coverslips were blocked with 0.5% albu-
min and 0.05% NaN3 in platelet buffer (blocking buffer) overnight, then in-
cubated at RT for 2 h with mouse anti-spectrin (#S3396; Sigma-Aldrich) or
rabbit anti- –adducin, each at a dilution of 1:250. The coverslips were
washed four times with blocking buffer, and incubated for 1 h at RT with a
1:200 dilution of Texas red–labeled anti–rabbit IgG for adducin combined
with F-actin staining; Alexa
® 488–labeled anti–rabbit IgG for adducin
combined with spectrin staining; and Alexa
® 568–labeled anti–mouse IgG
for all spectrin staining (Molecular Probes, Inc.). The coverslips were ex-
posed to 1  M phalloidin-Alexa
® 488 (Molecular Probes, Inc.) for F-actin
staining, washed four times with blocking buffer, and mounted (Aqua
Polymount; Polysciences) onto microscope slides. Images were recorded
digitally with a cooled CCD camera (Orca; Hamamatsu Corporation) on a
microscope (Eclipse PE2000; Nikon) using a 60  oil immersion objective
and MetaMorph
® software (Universal Imaging Corp.).
To monitor the effects of activation on the localization of spectrin, ad-
ducin, and F-actin, a time-course experiment was performed. Resting
platelets were centrifuged at 200 g for 1 min onto poly-L-lysine–coated
coverslips in platelet buffer with or without 5  M GF109203X. At times of
1.5 min or 5 min after the onset of centrifugation, the samples were then
fixed and extracted. Unstimulated platelets (time   0) were generated by
fixing resting platelets for 10 min, then centrifuging them onto poly-
L-lysine–coated coverslips. To quantitate the extent of colocalization of
spectrin and adducin with F-actin in platelets treated with or without GF
109203X, ratiometric imaging was performed using MetaMorph
® analysis
software (Universal Imaging Corp.). The images were digitally thresholded
with a software function that subtracts background signals below a critical
pixel density. Individual cells (n   10) for each condition and time point
were randomly selected, and the total area of fluorescence signal for actin,
spectrin, and/or adducin was measured for each platelet. The extent of as-
sociation between spectrin or adducin and F-actin is expressed as a per-
cent ratio of the overlapped area to the total area of actin signal.
Platelet actin assembly assay and FACS
® analysis
The F-actin content of platelets at various times after stimulation was quan-
titated by flow cytometry of FITC-phalloidin–labeled platelets in a FAC-
Scan™ (Beckton Dickinson). TRAP, IV.3 antibody, or PMA were used to
activate the platelets, in the presence or absence of 5  M GF 109203X. Af-
ter activation, the platelets were fixed for 30 min at the desired time point
by the addition of an equal vol of 6.8% formalin. A 1/40 vol of 4% Triton
X-100 containing 40  M FITC-phalloidin was used to extract platelets and
label the F-actin. Forward and side scattering were used to identify plate-
lets and measure the mean fluorescence of 10,000 cells.
Actin filament barbed-end exposure in platelets
The number of barbed ends per platelet was obtained in a nucleation assay
using pyrene-labeled actin (Hartwig, 1992; Hartwig et al., 1995). 90  l of
platelets at a concentration of 2   10
8/ml were activated with TRAP, IV.3
antibody, or PMA. Triton X-100–extracted platelets were diluted with
buffer B (0.1 M KCl, 0.2 mM MgCl2, 0.1 mM EGTA, 0.5 mM ATP, 10 mM
Tris, and 0.5 mM  -mercaptoethanol, pH 7.4) and 1  M monomeric
pyrene-labeled actin. The fluorescence data were gathered using a fluo-
rimeter (model LS-50B; PerkinElmer) with an excitation and emission
wavelength of 366 and 386 nm.
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